Synergic Control of Posture in Peripheral Neuropathies' Patients
NEUPER
1 other identifier
observational
26
1 country
2
Brief Summary
This is a multicenter observational study aimed to characterize multi-muscle synergy organization in relation to postural stability in individuals with Peripheral Neuropathies (PN) compared to healthy age-matched subjects and to assess the effectiveness of a rehabilitation program driven by multi-muscle synergy organization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2021
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 3, 2021
CompletedFirst Submitted
Initial submission to the registry
September 11, 2021
CompletedFirst Posted
Study publicly available on registry
October 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2024
CompletedJanuary 2, 2024
December 1, 2023
2.6 years
September 11, 2021
December 29, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
Evaluation of multi-muscle synergy organization using Synergy Index (SI)
Multi-muscle Synergy Index (SI) are new measurements of postural stability and a proxy of multi-muscle coordination. Synergy has been defined as a neural organization of a large set of effectors (e.g., muscles) providing stability of salient performance variables (e.g., center of pressure, COP). Within this framework, SI has been introduced, reflecting the relative amount of inter-trial variance that does not affect a performance variable.
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Evaluation of change in Anticipatory Synergy Adjustments (ASA)
ASAs represent changes in an index of a multi-muscle synergy stabilizing the coordinate of the center of pressure (COP). Such changes may be seen in young, healthy persons about 200-300 ms prior to the action initiation.
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Evaluation of balance
Evaluation of balance using Mini Balance Evaluation System Test (MiniBESTest). Each item is scored on a 0-4 scale; the scores are summed to obtain a total score of 28. The item are divided in four sessions: anticipatory, reactive postural control, sensory orientation, dynamic gait.
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Evaluation of balance
Evaluation of balance using Timed Up and Go test (TUG). It is a measure of the time taken by the patient for rising from a chair, walking three meters, turning and walking back to the chair to sit down.
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Evaluation of mobility
Evaluation of mobility using Six Minute Walking Test (6MWT). The 6MWT assesses distance walked over six minutes as a sub-maximal test of endurance/aerobic capacity.
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Secondary Outcomes (5)
Severity of chemotherapy induced-peripheral neuropathy
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Evaluation of change in electromyography (EMG) parameters
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Evaluation of change in electromyography (EMG) parameters
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Impact of PN on patients' quality of life
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Evaluation of change in level of disability
At baseline, after the 20th session of the rehabilitation program, follow up at 3 months
Study Arms (2)
Peripheral neuropathies patients
Peripheral neuropathies patients will be assessed at baseline, after a 20 session 2-3/w program of physical therapy and at a follow up of 3 months with: * Total Neuropathy Score-clinical version (TNSc©) * Nerve conduction studies * Short Form Health Survey 36 (SF-36) * Functional Independence Measure (FIM) * postural evaluation recording during three different postural tasks (quiet standing, voluntary sway and shoulder flexion):centre of pressure (COP) displacement of force platform; surface muscle activation using electromyography (EMG) of 13 muscle on the right side of the body (tibialis anterior, soleus,gastrocnemius lateralis-medialis, biceps femoris, semitendinosus, rectus femoris, vastus lateralis and medialis, tensor fasciae latae, lumbar and thoracic erector spinae and rectus abdominis) * Six Minute Walking Test (6MWT), Mini Balance Evaluation System Test (MiniBESTest) and Timed Up and Go test (TUG).
Healthy age-matched subjects
Healthy age-matched subjects will receive a postural evaluation recording during three different postural tasks (quiet standing, voluntary sway and shoulder flexion): * centre of pressure (COP) displacement of force platform; * surface muscle activation using electromyography (EMG) of 13 muscle on the right side of the body (tibialis anterior, soleus,gastrocnemius lateralis-medialis, biceps femoris, semitendinosus, rectus femoris, vastus lateralis and medialis, tensor fasciae latae, lumbar and thoracic erector spinae and rectus abdominis).
Interventions
The exercise intervention will consist of an individualized prescription of resistance training, balance training and cardiovascular exercises delivered for 20 session, one-hour, two/three times per week.
Eligibility Criteria
Peripheral neuropathy patients sent for a neurologic evaluation
You may qualify if:
- Subject suffering from peripheral neuropathy with a TNSc© score more than 4
- male and female subjects who are 18 years of age or older
You may not qualify if:
- orthopedic or neurologic comorbidities that can influence postural control
- A control group of healthy subjects with the same demographic features of peripheral neuropathy patients wil be also included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Cecilia Perin
Carate Brianza, Monza E Brianza, 20841, Italy
Paola Alberti
Monza, Monza E Brianza, 20900, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paola ALberti, MD, PhD
Università degli Studi di Milano Bicocca
- PRINCIPAL INVESTIGATOR
Cecilia Perin, MD
Università degli Studi di Milano Bicocca
- STUDY DIRECTOR
Guido Cavaletti, MD
Università degli Studi di Milano Bicocca
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2021
First Posted
October 22, 2021
Study Start
September 3, 2021
Primary Completion
April 1, 2024
Study Completion
April 1, 2024
Last Updated
January 2, 2024
Record last verified: 2023-12